A copper-delivery drug refolds damaged brain proteins in mice, reversing Parkinson’s symptoms and offering new avenues for human treatments.

In mice exhibiting tremors, rigidity, and slowed movement, targeted copper ions acted as molecular chaperones—binding and guiding misfolded proteins back into functional shapes. Treated animals regained motor control and balance within days, highlighting potential for disease-modifying therapies in neurodegenerative disorders.

Source: Good News Network